-
-
4-Amino-1-(5-O-(1，3，4，5，5-pentahydroxy-4-methyl-1，3，5-trioxido-2-oxa-1，3，5-triphosphapent-1-yl)-beta-D-arabinofuranosyl)-2(1H)-pyrimidinone,98%, 25mg
-
(E)-3-(2-Bromo-3，4-dihydroxy
phenyl)-N-(3，4，5-trihydroxybenzyl)prop-2-enethioamide,≥99%, 5mg
-
(E)-3-(2-Bromo-3，4-dihydroxy
phenyl)-N-(3，4，5-trihydroxybenzyl)prop-2-enethioamide,≥99%, 10mg
-
(R)-1-(3-Methylisoxazole-4-carbonyl)-10a-(6-methylpyridin-3-yl)-2，3，10，10a-tetrahydroimidazo[1，2-a]pyrrolo[1，2-d]pyrazin-5(1H)-one,98%, 5mg
-
(R)-1-(3-Methylisoxazole-4-carbonyl)-10a-(6-methylpyridin-3-yl)-2，3，10，10a-tetrahydroimidazo[1，2-a]pyrrolo[1，2-d]pyrazin-5(1H)-one,98%, 10mg
-
(R)-1-(3-Methylisoxazole-4-carbonyl)-10a-(6-methylpyridin-3-yl)-2，3，10，10a-tetrahydroimidazo[1，2-a]pyrrolo[1，2-d]pyrazin-5(1H)-one,98%, 25mg
-
3-Amino-3-methyl-N-[(3R)-2-oxo-1-[[4-[2-(2H-tetrazol-5-yl)
phenyl]
phenyl]methyl]-4，5-dihydro-3H-1-benzazepin-3-yl]butanamide,98%, 5mg
-
Y1 receptor antagonist 1,98%, 1mg
-
Y1 receptor antagonist 1,98%, 5mg
-
Prostaglandin J2 (PGJ2) in methyl acetate,98%, 1mg
-
Prostaglandin J2 (PGJ2) in methyl acetate,98%, 5mg
стр.: